Heart doctors report promising results with gene therapy
November 8, 1999
Web posted at: 1:47 p.m. EST (1847 GMT)
ATLANTA (CNN) -- Several heart doctors meeting in Atlanta this week reported success in experimental trials using gene therapy to help keep patients' arteries unclogged. And one researcher continued to defend his work from recent press reports that two deaths in a gene therapy experiment were not properly documented.
Gene therapy is cutting-edge research for heart disease. Cardiologists watch it eagerly, because half the 500,000 U.S. bypasses each year fail because the arteries clog up again with fatty plaque after surgery.
One of the most promising studies presented at the American Heart Association conference tested gene therapy along with bypass surgery for blocked leg arteries in 40 people. Before the procedure, patient Arnold Schutzberg could not walk without pain.
CNN's Rhonda Rowland reports on the new gene therapy treatment being used to help heart patients.
"I was living with that condition, having to stop every two blocks for a period of time until the blood flow managed to get through," he said.
During surgery, the veins to be used for the bypass were bathed in a solution of altered genes, designed to prevent the arteries from re-clogging.
Researchers followed the patients for a year and say the gene therapy has worked.
"We saw that the failure rate among this early group of patients who were at very high risk for failure was cut by more than half over that 12-month period," said Dr. Michael Mann, Boston Brigham & Women's Hospital.
Mann's tests of the genetic solution will now move to heart bypass surgeries.
Researchers say 2 deaths not caused by gene therapy
Dr. Jeffrey Isner runs some of the most advanced trials of gene therapy, currently involving 72 patients, and at the AHA meeting he again disputed recent charges that two deaths were not properly reported.
"Both of these cases were reported properly to the FDA. In both cases the FDA agreed they were not related to the gene therapy, and there was no need to interrupt the trial," said Isner.
Considering that he was working with very ill heart-disease patients, this was a low death rate, Isner added.
Summing up the latest gene therapy research in heart disease, Dr. Valentin Fuster told reporters, "Today we can say it is almost clinically applicable." Fuster is director of the cardiovascular institute at Mount Sinai Medical Center in New York.
Working heart valves for sheep grown in lab
In another experiment called "tissue engineering," researchers reported growing new heart valves for sheep in a laboratory and successfully implanting the working valves in six animals, who survived for several months.
Researchers started with cells from a lamb's own arteries, and they hope this approach will eventually produce better replacement valves for people.
Because they are made from the patient's own cells, the valves
could have at least two major advantages over the artificial valves and pig valves currently used: They will grow as the recipient does, and they will work without the need of blood-thinning drugs.
Medical Correspondent Rhonda Rowland and the Associated Press contributed to this story.
New treatments offer hope for heart disease patients
November 8, 1998
Holiday stresses may increase risk of heart disease
October 12, 1999
American Heart Association
National Heart, Lung, and Blood Institute (NHLBI)
Boston Brigham and Women's Hospital
St. Elizabeth's Medical Center of Boston
Note: Pages will open in a new browser window
External sites are not endorsed by CNN Interactive.
LATEST HEALTH STORIES:
China SARS numbers pass 5,000
Report: Form of HIV in humans by 1940
Fewer infections for back-sleeping babies
Pneumonia vaccine may help heart, too